151. Characterising the effects of per- and polyfluoroalkyl substances (PFASs) on health and disease: An opportunity for exposomics?
- Author
-
Bradley O Clarke, Mark P. Green, Jaye Marchiandi, Tarun Anumol, and Sonia Dagnino
- Subjects
Exposome ,Health, Toxicology and Mutagenesis ,0208 environmental biotechnology ,Public Health, Environmental and Occupational Health ,02 engineering and technology ,Disease ,010501 environmental sciences ,Health outcomes ,Critical research ,01 natural sciences ,020801 environmental engineering ,Human health ,Human disease ,Human exposure ,Environmental health ,Environmental Chemistry ,Psychology ,0105 earth and related environmental sciences ,Environmental epidemiology - Abstract
Human exposure to mixtures of perfluoroalkyl and polyfluoroalkyl substances (PFASs) constitutes an important issue in environmental epidemiology and the adoption of more holistic approaches to reduce the uncertainties associated with their human health effects is a critical research need. The ‘exposome’, defined as the totality of environmental (i.e. nongenetic) exposures from conception onward represents a new path towards understanding environmental determinants of human disease by assessing the multitude of exposures and risk of adverse health outcomes that occur over a lifetime. Here, we review the limitations of traditional approaches to PFAS health assessments and explore how the exposome approach may be able to address such issues. We discuss the advantages and disadvantages of exposomic research and its implementation into human health studies, and provide suggestions for future research to adopt the exposome approach to better characterise the overall influence of PFAS exposures on human health.
- Published
- 2020